These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32072817)

  • 1. Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial Fibrillation.
    Patel D; Druck A; Hoppensteadt D; Bansal V; Brailovsky Y; Syed M; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029619899702. PubMed ID: 32072817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.
    Holzwirth E; Kornej J; Erbs S; Obradovic D; Bollmann A; Hindricks G; Thiele H; Büttner P
    Clin Res Cardiol; 2020 Mar; 109(3):324-330. PubMed ID: 31236695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation.
    Odeh A; Dungan GD; Hoppensteadt D; Siddiqui F; Kantarcioglu B; Darki A; Fareed J; Syed MA
    Clin Appl Thromb Hemost; 2023; 29():10760296231165055. PubMed ID: 36941787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation.
    Odeh A; Dungan GD; Darki A; Hoppensteadt D; Siddiqui F; Kantarcioglu B; Fareed J; Syed MA
    Clin Appl Thromb Hemost; 2022; 28():10760296221145181. PubMed ID: 36514257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of CXC chemokine receptor 4 expression in chronic atrial fibrillation patients with mitral valve disease may be attenuated by renin-angiotensin system blockers.
    Wang XX; Zhang FR; Zhu JH; Xie XD; Chen JZ
    J Int Med Res; 2009; 37(4):1145-51. PubMed ID: 19761697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 in atrial remodeling in patients with atrial fibrillation.
    Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
    Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of vitamin D deficiency on atrial fibrillation.
    Demir M; Uyan U; Melek M
    Clin Appl Thromb Hemost; 2014 Jan; 20(1):98-103. PubMed ID: 22826443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
    Turin A; Bax JJ; Doukas D; Joyce C; Lopez JJ; Mathew V; Pontone G; Shah F; Singh S; Wilber DJ; Rabbat MG
    Am J Cardiol; 2018 Sep; 122(5):780-784. PubMed ID: 30057228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
    Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
    Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system blockade is associated with the long-term protection against cardiac remodeling after cardioversion in hypertensive patients with atrial fibrillation.
    Egami Y; Nishino M; Taniike M; Makino N; Kato H; Shutta R; Yamaguchi H; Tanouchi J; Yamada Y
    Tohoku J Exp Med; 2010 Jul; 221(3):251-5. PubMed ID: 20595797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-specific overexpression of (pro)renin receptor induces atrial fibrillation in mice.
    Lian H; Wang X; Wang J; Liu N; Zhang L; Lu Y; Yang Y; Zhang L
    Int J Cardiol; 2015 Apr; 184():28-35. PubMed ID: 25697868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
    Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
    Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
    Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of renin angiotensin system blockade in the treatment of atrial fibrillation.
    Dilaveris P; Giannopoulos G; Synetos A; Stefanadis C
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):387-403. PubMed ID: 16248831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Level Vitamin D Is Associated with Atrial Fibrillation in Patients with Chronic Heart Failure.
    Belen E; Aykan AC; Kalaycioglu E; Sungur MA; Sungur A; Cetin M
    Adv Clin Exp Med; 2016; 25(1):51-7. PubMed ID: 26935498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
    Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
    Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.
    Arslan A; Ozaydin M; Aksoy F; Arslan B; Bas HA; Erdogan D; Varol E; Dogan A
    Medicina (Kaunas); 2016; 52(2):104-9. PubMed ID: 27170483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction.
    Batra G; Lindhagen L; Andell P; Erlinge D; James S; Spaak J; Oldgren J
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.